Your browser doesn't support javascript.
loading
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency.
Kim, Olga; Butler, Madison; Sergi, Zach; Robey, Robert W; Zhang, Meili; Chari, Raj; Pang, Ying; Yu, Guangyang; Zhang, Wei; Song, Hua; Davis, Dionne; Hawley, Robert G; Wen, Xinyu; Wang, Herui; Quezado, Martha; Tran, Bao; Merchant, Mythili; Ranjan, Alice; Furnari, Frank B; Khan, Javed; Gilbert, Mark R; Ryan Miller, Christopher; Gottesman, Michael M; Pommier, Yves; Wu, Jing.
Afiliación
  • Kim O; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Butler M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Sergi Z; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Robey RW; Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Zhang M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Chari R; Genome Modification Core laboratory, Leidos Biomedical Inc/ Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Pang Y; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Yu G; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Zhang W; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Song H; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Davis D; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Hawley RG; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Wen X; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Wang H; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Quezado M; Laboratory of Pathology.
  • Tran B; Sequencing Facility, Leidos Biomedical Inc/ Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Merchant M; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Ranjan A; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Furnari FB; University of California at San Diego, School of Medicine, La Jolla, California, USA.
  • Khan J; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Ryan Miller C; The University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA.
  • Gottesman MM; Laboratory of Cell Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Pommier Y; Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
  • Wu J; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.
Neurooncol Adv ; 5(1): vdad102, 2023.
Article en En | MEDLINE | ID: mdl-37706203
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido